glp-1 obesity drug news today New Guidelines on Drugs for Released U.S. Obesity Rate Drops as

Ozempic (semaglutide) injection, for subcutaneous use

Researchers in JAMA Network Open reviewed the total cost of producing GLP-1 medications (as well as insulin and another classes of medicines used for diabetes) with an eye toward establishing a resource-based price so that these medications could be used to treat obesity and diabetes in low and middle income countries, where noncommunicable diseases such as heart disease and diabetes take a larger toll each year

The NHS recommends 68 cups or glasses of fluid daily , including water, lower-fat milk, sugar-free drinks, and tea or coffee

Coverage is highly plan-specific